Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Turcot syndrome × dostarlimab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Endometrial Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 4 Neoplasms 4 Colonic Neoplasms 4 Neoplasm Metastasis 3 Uterine Cervical Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Neoplasms 1 Turcot syndrome 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Sarcoma 1 Rectal Adenocarcinoma with Mismatch-repair Deficient (dMMR)/ Microsatellite Instability-high (MSI-H) 1 Penile Neoplasms 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Ovarian Carcinosarcoma 1 Oropharyngeal Neoplasms 1 Mouth Neoplasms 1 Locally Advanced Rectal Cancer (LARC) 1 Laryngeal Diseases 1 Hemangiosarcoma 1 Head and Neck Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Renal Cell 1

Interventions

pembrolizumab 2 toripalimab 1 sintilimab 1 fludarabine phosphate 1 fludarabine 1 dostarlimab 1 denileukin diftitox 1 Radiation Dose Hypofractionation 1 Nivolumab 1 Neoadjuvant Therapy 1 Ipilimumab 1 E7777 fusion protein 1 Cyclophosphamide 1 Celecoxib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06278857 2024-12-03

SATELLITE

Queensland Centre for Gynaecological Cancer

Phase 2 Recruiting

Turcot syndrome, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡